Cash flow Bruker Corporation

Equities

BRKR

US1167941087

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2025-12-04 pm EST			5-day change	1st Jan Change
48.38 ^USD	+1.09%		-1.33%	-17.47%

Nov. 24	Bruker Corporation acquired AST Revolution, LLC from Indaba Capital Management, L.P.	CI
Nov. 24	Bruker Buys AST Revolution	MT

05d30.5F-P24HFzA55r9SxE1HrpPY8sYPEbBh6lrYKXYZz7Ec.kWu_kfiJnGFI647XdWSOnJFj_-6qJHE74PxmaMkQnxawMd6V8oKiaT7muw

Published financial data: BRUKER CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	1.98B	2.41B	2.52B	2.95B	3.37B
Other Revenues, Total	6M	7.4M	6.2M	13.1M	-
Total Revenues	1.99B	2.42B	2.53B	2.96B	3.37B
Cost of Goods Sold, Total	1.04B	1.2B	1.22B	1.45B	1.68B
Gross Profit	944M	1.21B	1.31B	1.52B	1.68B
Selling General & Admin Expenses, Total	472M	563M	608M	730M	892M
Stock-Based Compensation (IS)	-	2.7M	-	-	-
R&D Expenses	198M	221M	236M	295M	376M
Other Operating Expenses	8.4M	1.2M	6.2M	10.9M	3.8M
Other Operating Expenses, Total	678M	788M	850M	1.04B	1.27B
Operating Income	266M	426M	456M	484M	410M
Interest Expense, Total	-14.4M	-14.3M	-16.1M	-16.4M	-47.9M
Interest And Investment Income	3.2M	900K	4.1M	7.5M	9.3M
Net Interest Expenses	-11.2M	-13.4M	-12M	-8.9M	-38.6M
Income (Loss) On Equity Invest.	-	-	1M	2M	-1.7M
Currency Exchange Gains (Loss)	-8M	-4.1M	-5.8M	-13.3M	23.7M
Other Non Operating Income (Expenses)	-	-	-	-3.1M	-
EBT, Excl. Unusual Items	247M	409M	440M	461M	394M
Restructuring Charges	-15.8M	-8.2M	-4.8M	-25.5M	-31.9M
Merger & Related Restructuring Charges	-3.2M	-6.8M	-19.7M	-11.7M	-119M
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-11.4M	-24.6M
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-2.1M	500K	-300K	-2.5M	-2.2M
Insurance Settlements	-	-	-	-	-
Other Unusual Items	-	-500K	-	136M	-11.2M
EBT, Incl. Unusual Items	226M	394M	415M	546M	205M
Income Tax Expense	64.4M	113M	116M	118M	91.4M
Earnings From Continuing Operations	161M	281M	298M	428M	114M
Net Income to Company	161M	281M	298M	428M	114M
Minority Interest	-3.6M	-3.5M	-1.9M	-1.3M	-700K
Net Income - (IS)	158M	277M	297M	427M	113M
Net Income to Common Incl Extra Items	158M	277M	297M	427M	113M
Net Income to Common Excl. Extra Items	158M	277M	297M	427M	113M
Per Share Items
Net EPS - Basic	1.03	1.83	2	2.92	0.76
Basic EPS - Continuing Operations	1.03	1.83	2	2.92	0.76
Basic Weighted Average Shares Outstanding	153M	151M	149M	146M	149M
Net EPS - Diluted	1.02	1.81	1.99	2.9	0.76
Diluted EPS - Continuing Operations	1.02	1.81	1.99	2.9	0.76
Diluted Weighted Average Shares Outstanding	155M	153M	149M	147M	150M
Normalized Basic EPS	0.98	1.66	1.84	1.96	1.65
Normalized Diluted EPS	0.97	1.65	1.83	1.95	1.64
Dividend Per Share	0.16	0.16	0.2	0.2	0.2
Payout Ratio	15.59	8.73	10.05	6.88	26.7
Supplemental Items
EBITDA	346M	515M	545M	599M	594M
EBITA	302M	464M	494M	531M	509M
EBIT	266M	426M	456M	484M	410M
EBITDAR	375M	544M	570M	639M	651M
Total Revenues (As Reported)	1.99B	2.42B	2.53B	2.96B	3.37B
Effective Tax Rate - (Ratio)	28.52	28.71	28.05	21.55	44.54
Current Domestic Taxes	-1M	2.2M	-7.9M	4.7M	11M
Current Foreign Taxes	85.4M	118M	135M	139M	144M
Total Current Taxes	84.4M	120M	127M	143M	155M
Deferred Domestic Taxes	-5.9M	-10.3M	-4.8M	-22.9M	-49.5M
Deferred Foreign Taxes	-14.1M	3.1M	-6.2M	-2.8M	-14.3M
Total Deferred Taxes	-20M	-7.2M	-11M	-25.7M	-63.8M
Normalized Net Income	151M	252M	273M	287M	245M
Interest on Long-Term Debt	14.4M	14.3M	16.1M	16.4M	47.9M
Non-Cash Pension Expense	3.3M	2.3M	1M	100K	-1.3M
Supplemental Operating Expense Items
Advertising Expense	9.7M	13.8M	19.3M	23.7M	27.8M
Research And Development Expense From Footnotes	198M	221M	236M	295M	376M
Net Rental Expense, Total	28.7M	29.2M	24.3M	40M	56.9M
Imputed Operating Lease Interest Expense	3.53M	2.79M	2.32M	3.9M	12.03M
Imputed Operating Lease Depreciation	25.17M	26.41M	21.98M	36.1M	44.87M
Stock-Based Comp., COGS (Total)	2M	2.2M	1.1M	1.4M	1.9M
Stock-Based Comp., R&D Exp. (Total)	2M	2.2M	1.3M	1.9M	2.7M
Stock-Based Comp., SG&A Exp. (Total)	9.3M	10.1M	13.3M	15.1M	17.1M
Stock-Based Comp., Other (Total)	2.7M	2.7M	12M	5.6M	3.6M
Total Stock-Based Compensation	16M	17.2M	27.7M	24M	25.3M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	682M	1.07B	646M	488M	183M
Short Term Investments	50M	100M	-	-	-
Trading Asset Securities, Total	7.6M	6.4M	14.8M	12M	10.7M
Total Cash And Short Term Investments	739M	1.17B	660M	500M	194M
Accounts Receivable, Total	377M	463M	534M	576M	667M
Other Receivables	-	-	-	45.9M	34.5M
Total Receivables	377M	463M	534M	622M	701M
Inventory	692M	710M	800M	968M	1.07B
Prepaid Expenses	-	-	-	26.7M	35.1M
Other Current Assets, Total	116M	124M	119M	47.1M	55M
Total Current Assets	1.92B	2.47B	2.11B	2.16B	2.05B
Gross Property Plant And Equipment	895M	901M	985M	1.22B	1.37B
Accumulated Depreciation	-432M	-435M	-447M	-524M	-559M
Net Property Plant And Equipment	463M	466M	538M	691M	815M
Long-term Investments	-	-	23M	8.3M	125M
Goodwill	320M	340M	458M	583M	1.51B
Other Intangibles, Total	229M	212M	271M	330M	912M
Accounts Receivable Long-Term	-	-	-	1.9M	4.3M
Deferred Tax Assets Long-Term	72M	90.1M	76.8M	297M	286M
Other Long-Term Assets, Total	39.6M	70.8M	132M	174M	104M
Total Assets	3.05B	3.65B	3.61B	4.25B	5.81B
Liabilities
Accounts Payable, Total	135M	147M	178M	203M	234M
Accrued Expenses, Total	198M	214M	211M	252M	300M
Current Portion of Long-Term Debt	5.7M	116M	16M	116M	27.9M
Current Portion of Leases	22.1M	19.6M	19.1M	28.4M	36.7M
Current Income Taxes Payable	98M	75.1M	85.5M	139M	120M
Unearned Revenue Current, Total	307M	336M	370M	400M	438M
Other Current Liabilities	26.7M	29.6M	33.7M	64.7M	125M
Total Current Liabilities	792M	938M	914M	1.2B	1.28B
Long-Term Debt	897M	1.24B	1.2B	1.17B	2.05B
Long-Term Leases	49.6M	44.4M	46.2M	90.6M	132M
Unearned Revenue Non Current	50.9M	50.2M	56.2M	91.5M	100M
Pension & Other Post Retirement Benefits	123M	105M	45.7M	76.6M	103M
Deferred Tax Liability Non Current	43.1M	46M	62.3M	67.7M	118M
Other Non Current Liabilities	119M	144M	154M	137M	208M
Total Liabilities	2.07B	2.57B	2.48B	2.84B	3.99B
Common Stock, Total	1.7M	1.7M	1.7M	1.7M	1.8M
Additional Paid In Capital	216M	238M	256M	283M	713M
Retained Earnings	1.41B	1.66B	1.93B	2.32B	2.41B
Treasury Stock	-667M	-820M	-1.08B	-1.24B	-1.24B
Comprehensive Income and Other	3.7M	-8.2M	14.8M	6M	-104M
Total Common Equity	961M	1.07B	1.11B	1.38B	1.78B
Minority Interest	13.1M	14.3M	18M	36.1M	34M
Total Equity	974M	1.08B	1.13B	1.41B	1.82B
Total Liabilities And Equity	3.05B	3.65B	3.61B	4.25B	5.81B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	152M	151M	147M	138M	152M
ECS Total Common Shares Outstanding	152M	151M	147M	145M	152M
Book Value / Share	6.32	7.1	7.58	9.49	11.74
Tangible Book Value	412M	519M	385M	464M	-639M
Tangible Book Value Per Share	2.71	3.44	2.62	3.2	-4.21
Total Debt	974M	1.42B	1.28B	1.41B	2.25B
Net Debt	235M	243M	622M	906M	2.05B
Debt Equivalent of Unfunded Proj. Benefit Obligation	125M	106M	47.5M	78.7M	106M
Debt Equivalent Oper. Leases	230M	234M	194M	320M	455M
Minority Interest, Total (Incl. Fin. Div)	13.1M	14.3M	18M	36.1M	34M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	199M	219M	301M	371M	389M
Inventories - Work In Process, Total	246M	255M	279M	315M	349M
Inventories - Finished Goods, Total	248M	236M	220M	282M	330M
Land - (BS)	36.5M	34.1M	36.6M	38.9M	47.5M
Buildings, Total	375M	372M	434M	498M	541M
Machinery, Total	417M	436M	463M	587M	640M
Full Time Employees	7.4K	7.76K	8.52K	9.71K	11.4K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	3M	4.2M	5.3M	4.6M	6.5M
Order Backlog	2.01B	2.08B	2.26B	2.23B	2.09B

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	158M	277M	297M	427M	113M
Depreciation & Amortization - CF	44.6M	51.7M	51.7M	67.8M	84.7M
Amortization of Goodwill and Intangible Assets - (CF)	35.8M	37.4M	37.1M	47.1M	99.1M
Depreciation & Amortization, Total	80.4M	89.1M	88.8M	115M	184M
(Gain) Loss From Sale Of Asset	-	-	-	-8.5M	4.6M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	15.4M	28.5M
Asset Writedown & Restructuring Costs	2.1M	-500K	300K	5.7M	2.2M
Stock-Based Compensation (CF)	16M	17.2M	27.7M	24M	25.3M
Other Operating Activities, Total	6.3M	25.1M	5.1M	-141M	-28M
Change In Accounts Receivable	40.8M	-95.3M	-67.9M	-900K	-40.6M
Change In Inventories	-91.6M	-67M	-138M	-125M	-69.8M
Change In Accounts Payable	-2.4M	61.4M	13.2M	23.1M	20.8M
Change in Unearned Revenues	68.6M	38.8M	52.7M	-600K	-52.8M
Change In Income Taxes	42.9M	-44.3M	-6.8M	43.7M	-15.3M
Change in Other Net Operating Assets	11.3M	-19.2M	2.6M	-28.1M	79.5M
Cash from Operations	332M	282M	274M	350M	251M
Capital Expenditure	-97.2M	-92M	-129M	-107M	-115M
Sale of Property, Plant, and Equipment	200K	4.9M	13.9M	11.1M	1.1M
Cash Acquisitions	-59.2M	-65M	-182M	-227M	-1.6B
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-45.1M	-50.3M	39.8M	-10M	-48.3M
Other Investing Activities, Total	8.6M	10M	6.2M	6.4M	4.8M
Cash from Investing	-193M	-192M	-252M	-326M	-1.76B
Short Term Debt Issued, Total	-	-	-	-	1.25B
Long-Term Debt Issued, Total	298M	493M	300K	-	974M
Total Debt Issued	298M	493M	300K	-	2.22B
Short Term Debt Repaid, Total	-	-	-	-	-1.21B
Long-Term Debt Repaid, Total	-306M	-3.1M	-111M	-21.5M	-135M
Total Debt Repaid	-306M	-3.1M	-111M	-21.5M	-1.35B
Issuance of Common Stock	3.3M	7M	2.8M	9.5M	409M
Repurchase of Common Stock	-123M	-153M	-263M	-152M	-
Common Dividends Paid	-24.6M	-24.2M	-29.8M	-29.4M	-30.2M
Common & Preferred Stock Dividends Paid	-24.6M	-24.2M	-29.8M	-29.4M	-30.2M
Other Financing Activities, Total	-8.8M	-500K	-14.5M	300K	-24.9M
Cash from Financing	-162M	319M	-415M	-193M	1.23B
Foreign Exchange Rate Adjustments	25.7M	-22.5M	-30.5M	12.2M	-28.7M
Net Change in Cash	3.6M	386M	-423M	-157M	-305M
Supplemental Items
Cash Interest Paid	28.7M	19.6M	24.3M	33.7M	54.6M
Cash Income Tax Paid (Refund)	43M	146M	147M	96.6M	154M
Levered Free Cash Flow	212M	198M	184M	292M	284M
Unlevered Free Cash Flow	221M	207M	194M	302M	314M
Change In Net Working Capital	-55.3M	73.3M	78.9M	32.6M	36.1M
Net Debt Issued / Repaid	-8.3M	490M	-111M	-21.5M	876M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	5.71	7.95	7.86	7.7	5.1
Return on Total Capital	8.79	11.97	11.61	11.56	7.48
Return On Equity %	16.88	27.25	26.93	33.67	7.05
Return on Common Equity	16.9	27.28	27.16	34.3	7.16
Margin Analysis
Gross Profit Margin %	47.52	50.2	51.65	51.25	50
SG&A Margin	23.74	23.28	24.04	24.61	26.51
EBITDA Margin %	17.43	21.31	21.55	20.21	17.65
EBITA Margin %	15.19	19.17	19.5	17.92	15.13
EBIT Margin %	13.39	17.62	18.04	16.33	12.19
Income From Continuing Operations Margin %	8.12	11.61	11.8	14.45	3.38
Net Income Margin %	7.94	11.46	11.72	14.41	3.36
Net Avail. For Common Margin %	7.94	11.46	11.72	14.41	3.36
Normalized Net Income Margin	7.58	10.42	10.78	9.67	7.29
Levered Free Cash Flow Margin	10.66	8.2	7.26	9.84	8.44
Unlevered Free Cash Flow Margin	11.11	8.57	7.65	10.19	9.33
Asset Turnover
Asset Turnover	0.68	0.72	0.7	0.75	0.67
Fixed Assets Turnover	4.76	5.21	5.04	4.82	4.47
Receivables Turnover (Average Receivables)	5.06	5.74	5.06	5.32	5.42
Inventory Turnover (Average Inventory)	1.64	1.72	1.62	1.63	1.65
Short Term Liquidity
Current Ratio	2.43	2.63	2.31	1.8	1.6
Quick Ratio	1.41	1.74	1.31	0.93	0.7
Operating Cash Flow to Current Liabilities	0.42	0.3	0.3	0.29	0.2
Days Sales Outstanding (Average Receivables)	72.33	63.6	72.07	68.6	67.54
Days Outstanding Inventory (Average Inventory)	222.72	212.54	225.23	223.31	221.35
Average Days Payable Outstanding	39.97	42.12	45.26	43.11	44.84
Cash Conversion Cycle (Average Days)	255.08	234.03	252.04	248.81	244.06
Long Term Solvency
Total Debt/Equity	100	130.7	113.32	99.51	123.69
Total Debt / Total Capital	50	56.65	53.12	49.88	55.3
LT Debt/Equity	97.15	118.15	110.22	89.29	120.14
Long-Term Debt / Total Capital	48.57	51.21	51.67	44.75	53.71
Total Liabilities / Total Assets	68.05	70.28	68.66	66.74	68.74
EBIT / Interest Expense	18.48	29.8	28.35	29.52	8.57
EBITDA / Interest Expense	26.06	38.07	35.38	38.96	13.59
(EBITDA - Capex) / Interest Expense	19.31	31.64	27.35	32.45	11.18
Total Debt / EBITDA	2.6	2.6	2.25	2.2	3.45
Net Debt / EBITDA	0.63	0.45	1.09	1.42	3.15
Total Debt / (EBITDA - Capex)	3.5	3.13	2.91	2.64	4.19
Net Debt / (EBITDA - Capex)	0.84	0.54	1.41	1.7	3.83
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-4.11	21.66	4.67	17.14	13.56
Gross Profit, 1 Yr. Growth %	-6.75	28.52	7.69	16.24	10.78
EBITDA, 1 Yr. Growth %	-11.65	48.69	5.95	9.85	-1.64
EBITA, 1 Yr. Growth %	-14.93	53.53	6.61	7.62	-5
EBIT, 1 Yr. Growth %	-15.95	60.13	7.26	6.05	-16.11
Earnings From Cont. Operations, 1 Yr. Growth %	-18.48	73.85	6.38	43.55	-73.44
Net Income, 1 Yr. Growth %	-19.98	75.6	7.04	44.03	-73.53
Normalized Net Income, 1 Yr. Growth %	-18.9	67.12	8.49	5.46	-15.34
Diluted EPS Before Extra, 1 Yr. Growth %	-19.05	77.45	9.94	45.73	-73.83
Accounts Receivable, 1 Yr. Growth %	-7.14	22.78	15.33	7.95	15.79
Inventory, 1 Yr. Growth %	19.94	2.57	12.67	21.02	10.28
Net Property, Plant and Equip., 1 Yr. Growth %	24.54	0.67	15.49	28.47	17.85
Total Assets, 1 Yr. Growth %	10.01	19.71	-1.05	17.67	36.63
Tangible Book Value, 1 Yr. Growth %	8.17	26.11	-25.79	20.45	-237.6
Common Equity, 1 Yr. Growth %	6	11.37	4.04	23.65	29.33
Cash From Operations, 1 Yr. Growth %	55.67	-14.99	-2.83	27.59	-28.22
Capital Expenditures, 1 Yr. Growth %	33.15	-5.35	40.43	-17.26	7.86
Levered Free Cash Flow, 1 Yr. Growth %	70.3	-6.34	-7.28	58.84	-3.61
Unlevered Free Cash Flow, 1 Yr. Growth %	64.33	-6.11	-6.42	55.88	2.97
Dividend Per Share, 1 Yr. Growth %	0	0	25	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	2.4	8.01	12.84	10.73	15.34
Gross Profit, 2 Yr. CAGR %	2.07	10.14	17.69	11.92	13.5
EBITDA, 2 Yr. CAGR %	0.94	16.44	25.59	7.95	4.13
EBITA, 2 Yr. CAGR %	-0.36	16.3	28.04	7.19	1.32
EBIT, 2 Yr. CAGR %	-1.67	18.31	31.18	6.74	-5.46
Earnings From Cont. Operations, 2 Yr. CAGR %	-5.57	19.04	35.99	23.58	-38.26
Net Income, 2 Yr. CAGR %	-6.29	18.54	37.1	24.16	-38.25
Normalized Net Income, 2 Yr. CAGR %	-3.57	18.89	34.79	6.85	-5.46
Diluted EPS Before Extra, 2 Yr. CAGR %	-5.41	19.85	39.68	26.58	-38.24
Accounts Receivable, 2 Yr. CAGR %	-0.79	6.78	19	11.53	11.79
Inventory, 2 Yr. CAGR %	16.56	10.92	7.5	16.77	15.52
Net Property, Plant and Equip., 2 Yr. CAGR %	30.79	11.97	7.83	21.81	23.04
Total Assets, 2 Yr. CAGR %	19.68	14.76	8.84	7.91	26.8
Tangible Book Value, 2 Yr. CAGR %	1.17	16.8	-3.26	-5.46	28.74
Common Equity, 2 Yr. CAGR %	3.54	8.65	7.65	13.42	26.46
Cash From Operations, 2 Yr. CAGR %	17.72	15.04	-9.12	11.34	-4.3
Capital Expenditures, 2 Yr. CAGR %	40.56	12.26	15.29	7.79	-5.53
Levered Free Cash Flow, 2 Yr. CAGR %	6.82	30.35	-6.75	21.49	23.85
Unlevered Free Cash Flow, 2 Yr. CAGR %	6.82	27.89	-6.21	20.91	26.81
Dividend Per Share, 2 Yr. CAGR %	0	0	11.8	11.8	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	4.02	8.45	6.88	14.26	11.66
Gross Profit, 3 Yr. CAGR %	4.75	10.22	9.31	17.21	11.54
EBITDA, 3 Yr. CAGR %	4.98	14.85	12.79	20.11	4.95
EBITA, 3 Yr. CAGR %	4.42	15.08	12.93	20.83	3.29
EBIT, 3 Yr. CAGR %	4.14	15.69	14.46	22.2	-1.16
Earnings From Cont. Operations, 3 Yr. CAGR %	26.2	15.74	14.66	38.47	-25.98
Net Income, 3 Yr. CAGR %	26.15	15.53	14.57	39.37	-25.82
Normalized Net Income, 3 Yr. CAGR %	4.18	15.83	15.27	24.04	-0.77
Diluted EPS Before Extra, 3 Yr. CAGR %	27.68	16.66	16.46	41.67	-25.15
Accounts Receivable, 3 Yr. CAGR %	5.7	6.52	9.56	15.16	12.92
Inventory, 3 Yr. CAGR %	12.5	11.69	11.5	11.83	14.57
Net Property, Plant and Equip., 3 Yr. CAGR %	20.21	19.86	13.13	14.31	20.47
Total Assets, 3 Yr. CAGR %	16.1	19.69	9.23	11.71	16.74
Tangible Book Value, 3 Yr. CAGR %	-4.53	8.88	0.41	4.07	7.14
Common Equity, 3 Yr. CAGR %	9.84	6.09	7.09	12.74	18.5
Cash From Operations, 3 Yr. CAGR %	29.1	5.62	8.74	1.76	-3.81
Capital Expenditures, 3 Yr. CAGR %	30.54	23.2	20.96	3.22	7.82
Levered Free Cash Flow, 3 Yr. CAGR %	67.93	2.24	16.3	11.36	12.87
Unlevered Free Cash Flow, 3 Yr. CAGR %	59.57	2.32	15.19	11.1	15
Dividend Per Share, 3 Yr. CAGR %	0	0	7.72	7.72	7.72
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.12	8.46	7.46	9.36	10.19
Gross Profit, 5 Yr. CAGR %	5.29	9.92	9.73	10.88	10.96
EBITDA, 5 Yr. CAGR %	7.99	14.47	12.73	11.99	9.35
EBITA, 5 Yr. CAGR %	8.23	15.09	13.23	11.8	8.25
EBIT, 5 Yr. CAGR %	7.82	15.44	14.14	11.96	6.15
Earnings From Cont. Operations, 5 Yr. CAGR %	9	12.68	30.03	18.81	-10.49
Net Income, 5 Yr. CAGR %	9.2	12.52	30.42	18.91	-10.52
Normalized Net Income, 5 Yr. CAGR %	8.57	15.32	15.41	12.08	6.61
Diluted EPS Before Extra, 5 Yr. CAGR %	11.2	13.76	32.35	20.53	-9.64
Accounts Receivable, 5 Yr. CAGR %	9.95	13.68	10.83	8.49	10.42
Inventory, 5 Yr. CAGR %	10.41	10.03	10.48	13.7	13.09
Net Property, Plant and Equip., 5 Yr. CAGR %	14.9	14.28	15.09	20.64	17
Total Assets, 5 Yr. CAGR %	12	15.08	13.14	14.83	15.94
Tangible Book Value, 5 Yr. CAGR %	-4.59	1.33	-4.03	2.9	10.91
Common Equity, 5 Yr. CAGR %	5.77	9.3	8.95	8.96	14.46
Cash From Operations, 5 Yr. CAGR %	7.71	16.64	12.19	7.87	3.32
Capital Expenditures, 5 Yr. CAGR %	23.23	19.92	24.21	16.79	9.57
Levered Free Cash Flow, 5 Yr. CAGR %	0.11	18.05	32.64	9.46	19.47
Unlevered Free Cash Flow, 5 Yr. CAGR %	0.18	16.95	28.94	9.31	19.9
Dividend Per Share, 5 Yr. CAGR %	-	0	4.56	4.56	4.56